Cloudian Gaining Increased Market Traction in Healthcare and Life Sciences
Will Showcase Storage Solutions to Manage Growing Healthcare Data Volumes Across EMR, EHR and PACS Systems at HIMSS19 Conference
SAN MATEO, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Cloudian, the innovation leader in enterprise object storage, today highlighted its expanding footprint in the healthcare and life sciences market, as organizations around the world turn to the company for help managing their rapidly growing digital assets and realizing the full value of these assets. Over the past year, Cloudian revenue from this market increased 75 percent, and its customer base now includes four national health agencies, one of the largest hospital operators in the U.S., a global pharmaceutical company and a range of other medical facilities and research institutes.
The Cure for Data Storage Ills
The proliferation of healthcare data is enabling advances such as improved diagnoses, new drug discoveries and genetic disease treatments. However, this data typically comes from various sources spread across different systems—from patient medical records in EMR and EHR systems to large amounts of unstructured content such as PET scans, MRIs, CT scans and X-rays in PACS systems—hindering the ability to bring all this data together for analysis and maximize its collective value.
Cloudian’s HyperStore solution provides a limitlessly scalable object storage platform that can consolidate information from these various systems in a cost-effective manner that also complies with HIPPA standards regarding the storage of personal medical information. HyperStore’s benefits include:
- Public cloud-like flexibility on-premises: Users can start small and non-disruptively add storage nodes as they need more capacity, with the added capacity becoming part of the available storage pool.
- Data management across the ecosystem: Cloudian seamlessly integrates with healthcare applications and Vendor Neutral Archive solutions to provide a central storage repository, enabling customers to consolidate storage and management of dispersed records and images for real-time, comprehensive viewing.
- Security and compliance: From data encryption at rest and in transit, to role-based access controls, to WORM (Write Once Read Many) capability, HyperStore includes extensive security features that meet stringent compliance requirements.
- Metadata tagging: In contrast to traditional SAN and NAS storage, Cloudian’s solution includes rich metadata tagging that greatly facilitates the application of machine learning and analytics for pattern detection, drug and disease research and even diagnoses.
- Data protection: HyperStore provides up to 14 nines of durability for long-term protection of healthcare and research data.
- Up to 70 percent cost savings: Built on industry-standard high-density servers, Cloudian reduces storage costs by up to 70 percent compared to traditional enterprise storage and public cloud offerings.
“Unifying healthcare data within a single repository and making it easily accessible to the right people at the right time is critical to driving more informed decision-making and, ultimately, better patient care,” said Sandra Lillie, global director, enterprise imaging sales and strategy at Hyland. “That’s why we value partners like Cloudian who join forces to break down information silos for our customers, facilitating better collaboration and making the vast stores of medical images, photos and documents available when and where they’re needed.”
Cloudian is featuring its HyperStore solution at the HIMSS19 Conference in Orlando, Fla., Feb. 9-15, booth #2888.
Cloudian turns information into insight with a hyperscale data fabric that lets customers store, find and protect data across the organization and around the globe. Cloudian data management solutions bring cloud technology and economics to the data center with uncompromising data durability, intuitive management tools and the industry’s most compatible S3 API. Cloudian and its ecosystem partners help Global 1000 customers simplify unstructured data management today while preparing for the data demands of AI and machine learning tomorrow. Learn more at www.cloudian.com.
+44 (0)1252 717040
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
The Delhi High Court in India has issued an injunction, restraining Sinopharm Weiqida from exporting its “Amoxycillin Trihydrate” product to India, as it infringes the patent of Centrient Pharmaceuticals19.2.2019 09:00:00 | Pressemelding
The High Court also found Sinopharm Weiqida guilty of Contempt of Court for failing to follow the previously granted preliminary injunction order ROTTERDAM, the Netherlands, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Centrient Pharmaceuticals (“Centrient”), the leading manufacturer of beta-lactam antibiotics, and a provider of next generation statins and anti-fungals, announced that the Delhi High Court in India has granted an injunction against Sinopharm Weiqida Pharmaceuticals and Sinopharm India, restricting the export and/or import into India of its active pharmaceutical ingredient (API) amoxicillin trihydrate. In addition, the Delhi High Court also found Sinopharm Weiqida prima facie guilty of contempt of Court for illegally importing amoxicillin active ingredients in contravention of the previously granted preliminary injunction in place in India since April 2017. The Court further found that Sinopharm Weiqida has infringed the patent of Centrient. Centrient, and its wholly owned subsidia
New Milestone for Cansativa Towards “EU GxP Innovation Hub”19.2.2019 07:15:00 | Pressemelding
Northern Swan invests millions in pharma startup Cansativa FRANKFURT, Germany, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Northern Swan, a New-York based investment firm, has invested several million euros in Cansativa GmbH, in order to further accelerate the growth of the company and its integration into the wider European market. Cansativa will use this investment to expand its current facilities to become a “EU GxP Innovation Hub” and fulfillment center for medical cannabis. This way, Cansativa helps promote the professionalization of the entire medical cannabis industry in Europe from its location in Frankfurt am Main, Germany. The new site will serve as the EU hub for the growing industry, granting pharmaceutical companies from all over the world access to the rapidly growing European market. Cansativa is poised to lend its support as a reliable, independent full-service GxP partner. "Unlike the majority of our competitors, we operate independently of third-party contractors – Ever since w
Juniper Systems Limited Launches New Cedar CT8 Rugged Tablet19.2.2019 05:16:00 | Pressemelding
Fully-Rugged Tablet Provides Global Connectivity, Better Performance BIRMINGHAM, United Kingdom, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Juniper Systems Limited today announced the release of the Cedar CT8™ Rugged Tablet, a high-performance Android® tablet made for rugged environments. The CT8 – the third Cedar tablet from Juniper Systems™ – marks a major upgrade in performance and GPS capability from its predecessor, the Cedar CT7G Rugged Tablet (2017 release). Packed behind its 8-inch high-visibility display is a Qualcomm Snapdragon 8-core processor running Android 8.1 with full Google® Mobile Services. This highly-efficient processor results in lower power consumption, less heat generated, and better overall performance. ‘The CT8 is fast, affordable, and it’s got rugged bones’, said Cody Draper, Juniper Systems’ Cedar product manager. ‘Job sites that need a formidable, cost-effective rugged tablet will find the CT8’s features easily meet and exceed those needs’. The CT8 Rugged Tablet also
INVNT No Longer Involved, As Bethel Woods Music and Culture Festival Changes Direction and Becomes Three Separate Events18.2.2019 23:37:00 | Pressemelding
NEW YORK, NY, Feb. 18, 2019 (GLOBE NEWSWIRE) -- INVNT, the global live brand storytelling agency™ today announces that it will not be producing Bethel Woods Music and Culture Festival: Celebrating the golden anniversary at the historic site of the 1969 Woodstock festival. The festival, which was planned for August 16-18, 2019 at Bethel Woods Center for the Arts, will now comprise three separate events over three days, and forms part of the venue’s Season of Song & Celebration commemorations, a year-long schedule of exhibits, programs and events. Scott Cullather, CEO, INVNT explained that the agency is proud of its support and contributions to the celebration plans and the global awareness that its efforts brought to Bethel Woods Center for the Arts, as a result. "INVNT will not be involved in the new format and we wish Bethel Woods and Live Nation, as well as the organizers of the other 50th anniversary celebrations taking place around the world, the very best," he said. "Bethel Woods
Align Technology Launches New iTero Element 5D Imaging System for Comprehensive Preventative and Restorative Oral Care at IDS18.2.2019 12:00:00 | Pressemelding
SAN JOSE, Calif., Feb. 18, 2019 (GLOBE NEWSWIRE) -- First intraoral scanner with near-infrared imaging (NIRI) technology that scans the internal structure of a tooth (enamel & dentin) in real time1. First integrated dental imaging system that simultaneously records 3D, intra-oral color and NIRI, and enables comparison over time using iTero® TimeLapse1. NIRI technology of the iTero Element® 5D system aids in detection and monitoring of interproximal caries lesions above the gingiva without using harmful radiation1. New web-based interface MyiTero.com complements visualization of the iTero Element 5D system. Limited-release direct doctor-lab workflow automatically sends scan to lab of choice. Align Technology, Inc. (NASDAQ: ALGN) today announced that it is launching the iTero Element 5D Imaging System, which provides a new comprehensive approach to clinical applications, workflows and user experience that expands the suite of existing high-precision, full-color imaging and fast scan time
General Electric Company: Dividend Declaration18.2.2019 08:00:00 | Pressemelding
FAIRFIELD, Conn., Feb. 18, 2019 (GLOBE NEWSWIRE) -- GE Board of Directors Authorizes Regular Quarterly Dividend The Board of Directors of GE (NYSE: GE) today declared a $0.01 per share dividend on the outstanding common stock of the Company. The dividend is payable April 25, 2019 to shareowners of record at the close of business on March 11, 2019. The ex-dividend date is March 8, 2019. About GE GE (NYSE:GE) drives the world forward by tackling its biggest challenges. By combining world-class engineering with software and analytics, GE helps the world work more efficiently, reliably, and safely. For more than 125 years, GE has invented the future of industry, and today it leads new paradigms in additive manufacturing, materials science, and data analytics. GE people are global, diverse and dedicated, operating with the highest integrity and passion to fulfill GE's mission and deliver for our customers. www.ge.com GE's Investor Relations website at www.ge.com/investor and our corporate b